KDL Biotech Shareholding Patterns

NSE: KOPDRUGS | BSE: 532291

₹2.14

₹-0.11 (-4.89%)

As on 16-Mar-2015IST

Market cap

₹5 Cr

Revenue (TTM)

₹26 Cr

P/E Ratio

P/B Ratio

-0.1

Div. Yield

0 %

Shareholder Type	Mar-13	Dec-12	Sep-12	Mar-12	Dec-11
Indian Promoter	45.39	45.39	45.39	45.39	45.39
Foreign Promoter	23.47	23.47	23.47	23.47	23.47
DIIs	2.46	2.46	2.46	2.46	2.46
Mutual Fund	0.01	0.01	0.01	0.01	0.01
FIIs	0.00	0.00	0.00	0.00	0.00
Others	28.67	28.67	28.67	28.67	28.67

Shareholding Pattern

Shareholder's Name	Category	Mar-13	Dec-12	Sep-12	Jun-12
Unimark Remedies Ltd	Promoter	45.39	45.39	45.39	--
Synpac Pharmaceuticals Ltd	Promoter	23.47	23.47	23.47	--
IDBI Bank Ltd	Public	2.03	2.03	2.03	--

Fund	Sep-02	Jun-02	Mar-02	Sep-00	Mar-00
Unit Trust of India	1.173	--	--	--	--

For fund wise information, Go to Who Owns What?

Figures given above are % of equity capital

Date	Person	Buy / Sell	Transaction Type	No. of Shares
25-Jul-2008	Unimark Remedies Ltd	Buy	Off Market	7,38,422
	Adarsh Somani	Sell	Off Market	4,500
	Claridge Investments Ltd.	Sell	Off Market	46,800
	Debonair Publications Ltd	Sell	Off Market	12,000
	G. Claridge & Co. Ltd.	Sell	Off Market	12,500

Shareholders more than 1%